Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1995 2
1997 4
1999 4
2000 1
2001 1
2002 5
2003 6
2004 4
2005 9
2006 10
2007 13
2008 5
2009 5
2010 5
2011 3
2012 3
2013 3
2014 5
2015 14
2016 6
2017 8
2018 4
2019 11
2020 15
2021 24
2022 19
2023 13
2024 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion.
Langezaal LCM, van der Hoeven EJRJ, Mont'Alverne FJA, de Carvalho JJF, Lima FO, Dippel DWJ, van der Lugt A, Lo RTH, Boiten J, Lycklama À Nijeholt GJ, Staals J, van Zwam WH, Nederkoorn PJ, Majoie CBLM, Gerber JC, Mazighi M, Piotin M, Zini A, Vallone S, Hofmeijer J, Martins SO, Nolte CH, Szabo K, Dias FA, Abud DG, Wermer MJH, Remmers MJM, Schneider H, Rueckert CM, de Laat KF, Yoo AJ, van Doormaal PJ, van Es ACGM, Emmer BJ, Michel P, Puetz V, Audebert HJ, Pontes-Neto OM, Vos JA, Kappelle LJ, Algra A, Schonewille WJ; BASICS Study Group. Langezaal LCM, et al. N Engl J Med. 2021 May 20;384(20):1910-1920. doi: 10.1056/NEJMoa2030297. N Engl J Med. 2021. PMID: 34010530 Clinical Trial.
ERASER.
Fiehler J, Thomalla G, Bernhardt M, Kniep H, Berlis A, Dorn F, Eckert B, Kemmling A, Langner S, Remonda L, Reith W, Rohde S, Möhlenbruch M, Bendszus M, Forkert ND, Gellissen S. Fiehler J, et al. Among authors: berlis a. Stroke. 2019 May;50(5):1275-1278. doi: 10.1161/STROKEAHA.119.024858. Stroke. 2019. PMID: 31009356 Clinical Trial.
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R, Higashida R, Marr A, Nguyen TN, Roux S, Smrčka M, Torné RT, Aldrich EF; on behalf of the REACT investigators. Mayer SA, et al. J Neurosurg. 2024 Aug 9:1-12. doi: 10.3171/2024.4.JNS232191. Online ahead of print. J Neurosurg. 2024. PMID: 39126720
Positionspapier der DRG, DGNR, GPR, DeGIR, ÖRG und DGP zur Nutzung klinischer Daten für wissenschaftliche Zwecke.
Kuhl C, Walter P, Zimmer C, Mentzel HJ, Reimer P, Hausegger KA, Baretton G, Hoffmann RT, Heindel W, Düber C, Uder M, Nikolaou K, Antoch G; Vorstand der Deutschen Röntgengesellschaft e. V. (DRG):; Vorstand der Deutschen Gesellschaft für Neuroradiologie e. V. (DGNR):; Vorstand der Gesellschaft für Pädiatrische Radiologie e. V. (GPR):; Vorstand der Deutschen Gesellschaft für Interventionelle Radiologie und Minimalinvasive Therapie (DeGIR):; Präsidium der Österreichischen Röntgengesellschaft (ÖRG):; Vorstand der Deutschen Gesellschaft für Pathologie e. V. (DGP):; Konferenz der Lehrstuhlinhaber für Radiologie e. V.:. Kuhl C, et al. Rofo. 2021 Apr;193(4):381-387. doi: 10.1055/a-1352-9747. Epub 2021 Feb 2. Rofo. 2021. PMID: 33530119 Free article. German. No abstract available.
Early Intubation in Endovascular Therapy for Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial.
Barlinn K, Langezaal LCM, Dippel DWJ, van Zwam WH, Roessler M, Roos YBWEM, Emmer BJ, van Oostenbrugge RJ, Gerber JC, Yoo AJ, Pontes-Neto OM, Mazighi M, Audebert HJ, Michel P, Schonewille WJ, Puetz V; BASICS Study Group. Barlinn K, et al. Stroke. 2023 Nov;54(11):2745-2754. doi: 10.1161/STROKEAHA.123.043669. Epub 2023 Sep 27. Stroke. 2023. PMID: 37871243 Free article. Clinical Trial.
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.
Bayas A, Mansmann U, Ön BI, Hoffmann VS, Berthele A, Mühlau M, Kowarik MC, Krumbholz M, Senel M, Steuerwald V, Naumann M, Hartberger J, Kerschensteiner M, Oswald E, Ruschil C, Ziemann U, Tumani H, Vardakas I, Albashiti F, Kramer F, Soto-Rey I, Spengler H, Mayer G, Kestler HA, Kohlbacher O, Hagedorn M, Boeker M, Kuhn K, Buchka S, Kohlmayer F, Kirschke JS, Behrens L, Zimmermann H, Bender B, Sollmann N, Havla J, Hemmer B; ProVal-MS study group. Bayas A, et al. Neurol Res Pract. 2024 Mar 7;6(1):15. doi: 10.1186/s42466-024-00310-x. Neurol Res Pract. 2024. PMID: 38449051 Free PMC article.
192 results